Text size :

Petruzzelli (Aladdin’s Lamp): “Oncological treatments should be equal for everyone, regardless of the territory”

ADNKRONOS

November 4, 2026

Rome, 4 Nov. (Adnkronos Health) – “Even in oncology, innovation is alive and is changing the quantity and quality of life. For us patients, however, it is fundamental that new treatments arrive quickly and certainly, and that access to care does not depend on the postal code. We cannot accept that the quality and quantity of care are conditioned by the territory in which one lives.” This was stated by Davide Petruzzelli, president of La Lampada di Aladino Ets and vice-president of Favo, at the ‘Generating innovation. Creating health’ meeting in Rome, during which the winning projects of the fifth edition of the Gilead Calls were announced.

Petruzzelli also indicated among the priorities the shift from a logic of healthcare provision to a true holistic care of the person. “In oncology, chronicity is increasingly discussed, and this requires a different approach: we must not limit ourselves to treating the organ, the cell, or mutations. Behind every treatment there are people, young and old, who work or do not work, and who have needs that go beyond the strictly healthcare dimension. This is the perspective in which to measure the real value of innovation.”

Regarding healthcare policies, the representative of patient associations recalled the need to implement the measures already foreseen. “New documents are not needed: what we have already written must be implemented. The National Oncology Plan 2023-2027 is largely still unimplemented, just as there are documents and agreements on territorial oncology, on the role of patient associations, and on the National Network for Rare Cancers. We simply ask that all this be translated into the real lives of sick people.”

Jiji Press

Related

Page TOP